• Dextran sulfate sodium salt in DSS Colitis Models

  2026-09-04

  Build a controlled mouse model of inflammatory bowel disease with DSS (MW 35000-45000), then separate epithelial injury from the repair response using matched molecular and histological readouts. This workflow connects barrier disruption, colonic epithelial apoptosis induction, and GPR35–KLF5 repair biology to practical ulcerative colitis research.

• Ultrasonic Implantable Tumor Treating Fields

  2026-09-04

  This 2026 MEMS study introduces a battery-free implantable Tumor Treating Field system powered through focused ultrasound and a shape-engineered BaTiO3 piezoelectric receiver. The platform generated localized therapeutic electric fields, inhibited glioblastoma proliferation in vitro, and reduced Ki-67 in a short pilot in vivo study, while highlighting important questions about dosimetry, implantation, and biological validation.

• Angiotensin (1-7): Applied Research Workflows

  2026-09-03

  Build cleaner RAS experiments with a high-purity Angiotensin (1-7) peptide, from Mas receptor signaling assays to fibrosis and inflammation models. A reference-driven workflow also shows how oral pathogens reshape angiotensin biology, helping researchers separate direct peptide effects from microbiome-mediated processing.

• SELENOK, CD36 Palmitoylation, and Aβ Clearance

  2026-09-03

  The reference study identifies a selenium–SELENOK–DHHC6–CD36 pathway that controls microglial membrane organization and amyloid-beta phagocytosis. Its gain- and loss-of-function experiments connect reduced CD36 palmitoylation with impaired Aβ clearance and show how selenium supplementation may restore this axis in Alzheimer’s disease models.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-09-02

  Gu et al. show that palbociclib can restrain pancreatic ductal adenocarcinoma growth while unexpectedly intensifying migration, invasion, and epithelial-to-mesenchymal transition. Adding the BET inhibitor JQ1 reverses this liability and produces synergistic antitumor activity by coordinating GSK3β-mediated Wnt/β-catenin signaling with TGF-β/Smad pathway crosstalk.

• Estradiol Workflows for ER Signaling Research

  2026-09-02

  Turn native 17 beta-estradiol into a controlled tool for receptor, transcriptional, autophagy, and organ-protection studies. This practical guide combines dose-response design, receptor-specific validation, multi-organ readouts, and troubleshooting for more interpretable estrogen biology.

• Protease Inhibitor Cocktail for RA-FLS Assays

  2026-09-01

  Protect RA-FLS, macrophage, and tissue lysates from multi-class proteolysis while preserving material for Western blotting, co-immunoprecipitation, and signaling studies. The separate EDTA component adds metalloprotease coverage, but its chelating activity requires deliberate handling in kinase, IMAC, and phosphoprotein workflows.

• NADPH Oxidase ROS Activate Ca2+ Channels in Rat Arteries

  2026-09-01

  The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream route by which NADPH oxidase-derived ROS enhance arterial contraction in early postnatal rats. Pharmacological comparison showed that this effect persisted after Rho-kinase, PKC, or Src-kinase inhibition but disappeared with L-type Ca2+ channel blockade, providing a useful framework for interpreting ROS-dependent vascular tone.

• nPEC for Dual-Loaded Liposome Analysis

  2026-08-31

  A 2025 Journal of Pharmaceutical Sciences study systematically compared methods for measuring encapsulation efficiency in liposomes carrying both hydrophilic and lipophilic drugs. Its validation of nanoparticle exclusion chromatography (nPEC) provides a practical, broadly applicable route for simultaneous analysis without extensive sample pretreatment.

• Panobinostat (LBH589) Research Workflows

  2026-08-31

  Panobinostat (LBH589) links broad HDAC inhibition to measurable chromatin, apoptotic, and extracellular-matrix phenotypes. This practical guide shows how to build cancer and scleral macrophage workflows around the compound while separating validated findings from optimization starting points.

• DIDS: From Chloride Transport to Metastatic States

  2026-08-30

  DIDS is more than a conventional chloride channel blocker: it is a broad mechanistic probe that can connect ion transport, mitochondrial stress, tumor-cell survival, and translational assay design. This article examines how DIDS can be used to interrogate prometastatic states while preserving appropriate controls for specificity, formulation, and biological interpretation.

• Pretomanid Inhibits Both TB Terminal Oxidases

  2026-08-29

  The reference study identifies the cytochrome bcc:aa3 and bd terminal oxidases as functional respiratory targets of pretomanid, also known as PA-824. Its genetic and chemical biology evidence supports rational combinations with telacebec and ND-011992 to improve bactericidal activity against replicating and antibiotic-tolerant Mycobacterium tuberculosis while limiting resistance emergence.

• GSK621: Reading AMPK in Immunometabolic Assays

  2026-08-28

  GSK621 is a potent AMPK agonist for resolving energy-sensing, autophagy, lipid metabolism, and leukemia-associated phenotypes. This article presents an assay-architecture framework that separates AMPK pathway activation from cell-state interpretation and connects AML findings with immunometabolic research.

• Vancomycin Workflows for Microbiome Research

  2026-08-28

  Learn how to deploy Vancomycin as a controlled bacterial cell wall perturbation tool in MRSA, resistance, and microbiome–immune experiments. This workflow-focused guide connects peptidoglycan precursor binding with practical culture assays, antibiotic-perturbation controls, and troubleshooting for immune readouts.

• Oseltamivir Acid: Assay-to-Model Translation

  2026-08-27

  Oseltamivir acid is an influenza neuraminidase inhibitor whose value depends on connecting enzyme inhibition with cellular, resistance, and translational readouts. This article presents an assay-to-model framework informed by humanized-mouse pharmacokinetic research, while clearly separating direct evidence from practical recommendations.

8128 records 1/542 page Next 12345 下5页 Last page